Companies · Pharmaceuticals

Bpv-1 Llc

WEST CHESTER · Pharmaceuticals

Diligence memoA one-page analyst read on Bpv-1 Llc — recommendation, valuation, rhythm, risks.→
$2.0M
Total raised · real
1
Rounds
—
Latest step-up
Top 73%
Sector rank · raised
Seed
Latest stage · inferred · Mon Jul 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Bpv-1 Llc looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the pharma sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.33× the median modeled value of Seed Pharmaceuticals companies in 2019–2021 (49 peers) — value vs value, same stage and era.
  • Within the normal band (133% of peer median) for its niche.
Dormant
  • Last raise 7.0 yr ago; this sector typically re-raises about every 13 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Bpv-1 Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
7.3 yr record
Peak capital year was 2019 with $2.0M across 1 filings.
Market position
ahead of 28% of Pharmaceuticals peers
Capital scale is ahead of 28% of Pharmaceuticals peers; modeled value is above 50% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2019: $2.0M across 1 filings.
  • Largest single filing was $2.0M on 2019-07-01.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Pharmaceuticals

Bpv-1 Llc is one of 1613 Pharmaceuticals companies tracked from WEST CHESTER. By capital raised it ranks in the long tail (ahead of 28% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
No revenue
Issuer revenue
Rule 506(b)
Reg D exemption
2019
Year incorporated
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2019-07-01 Raised $2.0M (real) Modeled valuation $76M (est)$2.0M$76MSeed2019

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.0M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$76.1M
Base estimate est.
$1.5M
Conservative case
$597.0M
Upside case
$10.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the pharma sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
34%
Survival probability
15% low · 52% high
1.68×/yr
Annual markup
2.20×/yr upside case
6.0 yr
Elapsed time used
7.0 yr actual, capped for stale marks
pharma
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
—
Avg between rounds
—
Capital velocity
7.3 yr
On record since
2019
First round
1
Rounds on file
How it compares to the market

Benchmarked against 1613 companies in Pharmaceuticals. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)▼ 0.2× of median
This company$2.0M
Sector median$8.1M
Latest round — vs other Seed rounds in sector (real $, this stage)▲ 1.2× above median
This company$2.0M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages)▲ 1.0× above median
This company$76.1M
Sector median$76.1M

Raised more than 28% of sector peers (real $). Modeled value above 50% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #17 of 49.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Wiesman Capital & Co., LLC · Seed Raised $4.0M · modeled $152.2M (est)Curzion Pharmaceuticals, Inc. · Seed Raised $3.5M · modeled $133.1M (est)Providence Therapeutics Inc. · Seed Raised $8.1M · modeled $132.2M (est)EnBiotix, Inc. · Seed Raised $6.6M · modeled $131.8M (est)Metuchen Pharmaceuticals, LLC · Seed Raised $3.1M · modeled $119.2M (est)VasoRx, Inc. · Seed Raised $4.7M · modeled $117.9M (est)Amplicore Inc. · Seed Raised $2.8M · modeled $107.1M (est)Lamassu Pharma, LLC · Seed Raised $2.7M · modeled $101.5M (est)Apertor Pharmaceuticals, Inc. · Seed Raised $3.0M · modeled $95.3M (est)Elgia Therapeutics, Inc. · Seed Raised $2.3M · modeled $88.6M (est)Pharmapotheca A, LLC · Seed Raised $3.1M · modeled $87.3M (est)ImmunoRx Pharma, Inc. · Seed Raised $2.7M · modeled $82.2M (est)Bpv-1 Llc (this company) Raised $2.0M · modeled $76.1M (est)Bpv-1 Llc
CompanyStageRaised · realValue · estvs peer med.
Wiesman Capital & Co., LLCSeed$4.0M$152.2M2.67×
Curzion Pharmaceuticals, Inc.Seed$3.5M$133.1M2.33×
Providence Therapeutics Inc.Seed$8.1M$132.2M2.32×
EnBiotix, Inc.Seed$6.6M$131.8M2.31×
Metuchen Pharmaceuticals, LLCSeed$3.1M$119.2M2.09×
VasoRx, Inc.Seed$4.7M$117.9M2.07×
Amplicore Inc.Seed$2.8M$107.1M1.88×
Lamassu Pharma, LLCSeed$2.7M$101.5M1.78×
Apertor Pharmaceuticals, Inc.Seed$3.0M$95.3M1.67×
Elgia Therapeutics, Inc.Seed$2.3M$88.6M1.55×
Pharmapotheca A, LLCSeed$3.1M$87.3M1.53×
ImmunoRx Pharma, Inc.Seed$2.7M$82.2M1.44×
Bpv-1 Llc this companySeed$2.0M$76.1M1.33×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.0M2019-07-01$10.0M$76.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.0M2019-07-01
    • First recorded raise — entered as Seed.
Intelligence
—
Modeled next raise
$3.2M
Modeled next size est.range $2.1M–$5.1M
—
Last step-up
—
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Brian Anderson—6 other2019-07
Gregory Doll——2019-07
Gregory Schuster——2019-07
Registry & provenance

Bpv-1 Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1789898
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Capitol Wellness Solutions LLCPharmaceuticalsSeed$2.0M$76.1Msame sector · same stage
LGM Holdings, LLCPharmaceuticalsSeed$2.0M$35.3Msame sector · same stage
Neurotez Inc.PharmaceuticalsSeed$2.0M$76.1Msame sector · same stage
PhytoCeutica, Inc.PharmaceuticalsSeed$2.0M$76.1Msame sector · same stage
Rundle Research LLCPharmaceuticalsSeed$2.0M$76.1Msame sector · same stage
Stromedix IncPharmaceuticalsSeed$2.0M$76.1Msame sector · same stage
Biomerica IncPharmaceuticalsSeed$2.0M$76.1Msame sector · same stage
Medsource-Direct, Inc.PharmaceuticalsSeed$2.0M$74.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
DBV Technologies S.A.PharmaceuticalsSeries D+$2.6B85%
PMV Pharmaceuticals, Inc.PharmaceuticalsSeries C$2.6B81%
Enumeral Biomedical Holdings, Inc.PharmaceuticalsSeries B$22.7M78%
BTB Therapeutics, Inc.PharmaceuticalsSeed$7.9M78%
LP Investors, LLCPharmaceuticalsSeries B$1.4B78%
SapVax, LLCPharmaceuticalsSeed$123.6M78%
Dauntless 1, Inc.PharmaceuticalsSeries A$247.8M78%
Juva Life, Inc.PharmaceuticalsSeries A$168.8M78%
Frequently asked
How much funding has Bpv-1 Llc raised?
Bpv-1 Llc has raised approximately $2.0M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Bpv-1 Llc's estimated valuation?
Provath's modeled valuation for Bpv-1 Llc is approximately $76.1M (modeled range $1.5M–$597.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Bpv-1 Llc at?
Bpv-1 Llc's latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Jul 01.
What does Bpv-1 Llc do and where is it based?
Bpv-1 Llc operates in the Pharmaceuticals sector, based in WEST CHESTER.
Explore related

See where Bpv-1 Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Bpv-1 Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.